Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
In-house newspaper/magazine
A form of media used by a company or organisation to communicate to employees about internal about news, issues and developments.
See also:
In-house
Company-specific training
Related terms
Advertising agency's commission, Collateral PR, Duplication, Above the line, Media planning, Column inches, Direct response advertising (DRA), Tonal bias, Exclusive, Press release, Full-service agency, Media mix, Ambient media, Opportunities to see (OTS), Below the line ,
COVID-19 Updates and Daily News
Featured jobs
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
-
Consultant Dermatologist (Freelance)
-
£110-180ph
-
Senior Health Psychologist, London
-
Highly competitive salary
- Recognising HIV Vaccine Awareness Day
- Scientists discover new approach to treat brain tumours
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
- Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients
- J&J appoints Thibaut Mongon as CEO designate of New Consumer Health Company
- Sanofi and Regeneron receive FDA approval for eosinophilic oesophagitis treatment
- AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster
- Positive CHMP opinion issued for PTC Therapeutics’ Upstaza
- Live Webinar: The Future of MedTech: Streamlined Clinical Data Collection & Management
- Medscape: Connect to the conversation
- A Medscape 4-part video interview series
- Roche shares new positive Ocrevus data for MS patients
- First trial of a vaccine against Alzheimer’s launches
- Boehringer bolsters KRAS push with $720m Lupin deal
- Getting patients to engage with clinical trials
- MHRA approves Infex Therapeutics’s study for treatment for non-cystic fibrosis patients
- Sanofi launches new funding foundation
